SWOG Presents 30 Abstracts at ASCO 2023 | SWOG “Here are highlights from some of the other SWOG work to be presented at ASCO 2023…
Read MoreSWOG’s ASCO 2023 preview highlights Goldkorn Lab liquid biopsy research in two abstracts
The February issue of National Geographic magazine featured an article providing readers with a broad overview of what liquid biopsies are and what they have…
Goldkorn Lab presents research into cell-free DNA methylation at ASCO 2022
Posted in Conference, Research, and Video
The ASCO 2022 annual meeting was held last month, and on June 3rd, the Goldkorn Lab presented an oral abstract showcasing research done in cooperation…
Read MoreGoldkorn Lab presents research into cell-free DNA methylation at ASCO 2022
Amir joins Dr. Tom Powles and Dr. Brian Rini on the Kidney Cancer Association’s Uromigos podcast to discuss the results of the S1314 clinical trial,…
By Hinde Kast (Originally posted at USC Norris Cancer) Cancer can evolve and adapt during therapy, leading to resistance and progression. New non-invasive technologies can…
“Drs. Amir Goldkorn, Timothy Triche, and Vinay Duddalwar awarded a new multi-investigator R01 grant from the National Cancer Institute for translational biomarker studies in advanced…
Read MoreLiquid Biopsy Core Research featured in May/June 2021 NCCC Community for a Cure Newsletter
From CancerNetwork: “Men with metastatic castrate resistant prostate cancer (mCRPC) with undetectable circulating tumor counts (CTCs) were 6.1-fold more likely to have complete response to…
Read MoreAmir discusses SWOG S1216 next steps with CancerNetwork
“Amir Goldkorn, MD, of USC Norris Comprehensive Cancer Center, discusses findings from SWOG S1216, which showed that using circulating tumor cell (CTC) count at…
Watch it here: New biomarker may guide initial treatment of metastatic prostate cancer – Keck Medicine of USC (broadcastmed.net) “Prostate cancer is the most common…
Read MoreAmir presents S1216 results at the 2020 ASCO Annual Meeting